Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Drug Deliv Transl Res. 2014 Apr 1;4(2):203–209. doi: 10.1007/s13346-013-0190-7

Fig. 1.

Fig. 1

In vitro and in vivo characterizations of PTX/PEG-PSA particles. (a) Scanning electron micrograph, (b) volume-weighted size distribution, and (c) in vitro release kinetics for PTX/PEG-PSA particles. (d) Intraperitoneal retention of PTX delivered by Taxol® or PTX/PEG-PSA particles. Data represent mean ± S.E.M. (n = 3). * indicates statistical differences at all time points (p < 0.05)